Abera Bioscience
6,30 SEK
+0,80 %
Mindre end 1K følgere
ABERA
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Oversigt
Finansielt overblik og estimater
Ejerskab
Dividend
Investorkonsensus
+0,80 %
-3,82 %
-7,35 %
-4,55 %
-19,75 %
+6,78 %
+35,19 %
-47,50 %
-42,99 %
Abera Bioscience operates in biotechnology. The company specializes in the development of vaccines based on a proprietary and patented platform. The technology is mainly used in the development of new vaccines, with a focus on the main areas of pneumococci and immuno-oncology. The operations are located throughout the Nordic market. The company was founded in 2012 and is headquartered in Solna.
Læs mereMarkedsværdi
129,14 mio. SEK
Aktieomsætning
5,45 t SEK
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Omsætning og EBIT-margin
Omsætning
EBIT-% (adj.)
EPS og udbytte
EPS (adj.)
Udbytte %
Finanskalender
12.5
2026
Delårsrapport Q1'26
10.6
2026
Generalforsamling '26
20.8
2026
Delårsrapport Q2'26